|
PPIP5K2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.67508237783431E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.39589492479331E-11 |
| Normal-vs-Stage2 |
4.02299999979761E-07 |
| Normal-vs-Stage3 |
2.2165003166208E-10 |
| Normal-vs-Stage4 |
6.80720002588231E-09 |
| Stage1-vs-Stage2 |
6.317200E-01 |
| Stage1-vs-Stage3 |
1.487170E-01 |
| Stage1-vs-Stage4 |
1.197980E-01 |
| Stage2-vs-Stage3 |
6.064400E-01 |
| Stage2-vs-Stage4 |
4.338200E-01 |
| Stage3-vs-Stage4 |
7.001200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.21225293429006E-12 |
| Normal-vs-AfricanAmerican |
2.188300E-04 |
| Normal-vs-Asian |
2.71009999996963E-07 |
| Caucasian-vs-AfricanAmerican |
5.879400E-01 |
| Caucasian-vs-Asian |
9.216800E-01 |
| AfricanAmerican-vs-Asian |
6.768800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11889997267411E-09 |
| Normal-vs-Female |
4.53848070236518E-12 |
| Male-vs-Female |
8.825200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.55780005456552E-09 |
| Normal-vs-Age(41-60Yrs) |
4.02733402182776E-12 |
| Normal-vs-Age(61-80Yrs) |
2.70459987739002E-10 |
| Normal-vs-Age(81-100Yrs) |
8.502000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.472100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.041960E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.257600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.483600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.591610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.841030E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.956200E-02 |
| Classical-VS-Follicular |
2.005600E-01 |
| Classical-VS-Other |
9.209000E-01 |
| Classical-VS-Normal |
3.96640054134423E-10 |
| Tall-VS-Follicular |
4.818000E-01 |
| Tall-VS-Other |
4.784000E-01 |
| Tall-VS-Normal |
2.9000000001389E-07 |
| Follicular-VS-Other |
7.599400E-01 |
| Follicular-VS-Normal |
8.99829999401192E-09 |
| Other-VS-Normal |
1.874070E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.10398365396713E-12 |
| Normal-vs-N1 |
3.80789999976372E-07 |
| N0-vs-N1 |
5.074000E-01 |
|
|
